These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31965454)

  • 1. Minocycline for Depressive Symptoms: a Meta-Analysis of Randomized, Double-Blinded, Placebo-Controlled Trials.
    Cai DB; Zheng W; Zhang QE; Ng CH; Ungvari GS; Huang X; Xiang YT
    Psychiatr Q; 2020 Jun; 91(2):451-461. PubMed ID: 31965454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive minocycline for major mental disorders: A systematic review.
    Zheng W; Zhu XM; Zhang QE; Cheng G; Cai DB; He J; Ng CH; Ungvari GS; Peng XJ; Ning YP; Xiang YT
    J Psychopharmacol; 2019 Oct; 33(10):1215-1226. PubMed ID: 31294649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials.
    Köhler-Forsberg O; N Lydholm C; Hjorthøj C; Nordentoft M; Mors O; Benros ME
    Acta Psychiatr Scand; 2019 May; 139(5):404-419. PubMed ID: 30834514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia.
    Solmi M; Veronese N; Thapa N; Facchini S; Stubbs B; Fornaro M; Carvalho AF; Correll CU
    CNS Spectr; 2017 Oct; 22(5):415-426. PubMed ID: 28181901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
    Oya K; Kishi T; Iwata N
    Hum Psychopharmacol; 2014 Sep; 29(5):483-91. PubMed ID: 25087702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials.
    Xiang YQ; Zheng W; Wang SB; Yang XH; Cai DB; Ng CH; Ungvari GS; Kelly DL; Xu WY; Xiang YT
    Eur Neuropsychopharmacol; 2017 Jan; 27(1):8-18. PubMed ID: 27919523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials.
    Bai S; Guo W; Feng Y; Deng H; Li G; Nie H; Guo G; Yu H; Ma Y; Wang J; Chen S; Jing J; Yang J; Tang Y; Tang Z
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):21-32. PubMed ID: 31658959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.
    Köhler O; Benros ME; Nordentoft M; Farkouh ME; Iyengar RL; Mors O; Krogh J
    JAMA Psychiatry; 2014 Dec; 71(12):1381-91. PubMed ID: 25322082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid/methylfolate for the treatment of psychopathology in schizophrenia: a systematic review and meta-analysis.
    Sakuma K; Matsunaga S; Nomura I; Okuya M; Kishi T; Iwata N
    Psychopharmacology (Berl); 2018 Aug; 235(8):2303-2314. PubMed ID: 29785555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of minocycline for depression: A systematic review and meta-analysis of clinical trials.
    Rosenblat JD; McIntyre RS
    J Affect Disord; 2018 Feb; 227():219-225. PubMed ID: 29102836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetyl-L-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-Analysis.
    Veronese N; Stubbs B; Solmi M; Ajnakina O; Carvalho AF; Maggi S
    Psychosom Med; 2018; 80(2):154-159. PubMed ID: 29076953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minocycline in depression not responding to first-line therapy: A systematic review and meta-analysis.
    Shamim MA; Manna S; Dwivedi P; Swami MK; Sahoo S; Shukla R; Srivastav S; Thaper K; Saravanan A; Anil A; Varthya SB; Singh S; Shamim MA; Satapathy P; Chattu SK; Chattu VK; Padhi BK; Sah R
    Medicine (Baltimore); 2023 Nov; 102(45):e35937. PubMed ID: 37960804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of minocycline in depressive patients with or without treatment-resistant: a meta-analysis of randomized controlled trials.
    Qiu Y; Duan A; Yin Z; Xie M; Chen Z; Sun X; Wang Z; Zhang X
    Front Psychiatry; 2023; 14():1139273. PubMed ID: 37342175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials.
    Kishi T; Miyake N; Okuya M; Sakuma K; Iwata N
    Psychopharmacology (Berl); 2020 Nov; 237(11):3481-3487. PubMed ID: 32767039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins for the treatment of depression: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Salagre E; Fernandes BS; Dodd S; Brownstein DJ; Berk M
    J Affect Disord; 2016 Aug; 200():235-42. PubMed ID: 27148902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis.
    Coventry PA; Meader N; Melton H; Temple M; Dale H; Wright K; Cloitre M; Karatzias T; Bisson J; Roberts NP; Brown JVE; Barbui C; Churchill R; Lovell K; McMillan D; Gilbody S
    PLoS Med; 2020 Aug; 17(8):e1003262. PubMed ID: 32813696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
    Martins JG
    J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zheng W; Cai DB; Yang XH; Ungvari GS; Ng CH; Müller N; Ning YP; Xiang YT
    J Psychiatr Res; 2017 Sep; 92():139-146. PubMed ID: 28445800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosocial interventions for preventing and treating depression in dialysis patients.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Rabindranath KS; Strippoli GF
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004542. PubMed ID: 31789430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.